Feedback / Questions
Undisclosed second generation c-abl inhibitor - Inhibikase
risvodetinib (IkT-148009) - Inhibikase, Clintrex
https://www.prnewswire.com/news-releases/inhibikase-therapeutics-initiates-development-of-second-generation-c-abl-inhibitors-and-names-ikt-148009-as-risvodetinib-301904847.html
Aug 21, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next